# Study of Atomoxetine and OROS Methylphenidate to Treat Children and Adolescents Ages 6-17 With ADHD

> **NCT00585910** · PHASE4 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 94 (actual)

## Conditions studied

- ADHD
- Attention Deficit Hyperactivity Disorder

## Interventions

- **DRUG:** Atomoxetine and OROS Methylphenidate

## Key facts

- **NCT ID:** NCT00585910
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 94 (ACTUAL)
- **Last updated:** 2012-11-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00585910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00585910, "Study of Atomoxetine and OROS Methylphenidate to Treat Children and Adolescents Ages 6-17 With ADHD". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00585910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*